Anticancer Ru and Os complexes of N-(4-chlorophenyl)pyridine-2-carbothioamide: Substitution of the labile chlorido ligand with phosphines-Reference-Cited by-同舟云学术

Anticancer Ru and Os complexes of N-(4-chlorophenyl)pyridine-2-carbothioamide: Substitution of the labile chlorido ligand with phosphines

Published:2023-04 Issue: Volume:241 Page:112115
ISSN:0162-0134
Container-title:Journal of Inorganic Biochemistry
language:en
Short-container-title:Journal of Inorganic Biochemistry

Author:

Riaz Zahid,Lee Betty Y.T.,Stjärnhage Julia,Movassaghi Sanam,Söhnel Tilo,Jamieson Stephen M.F.,Shaheen Muhammad Ashraf,Hanif Muhammad,Hartinger Christian G.

Funder

Higher Education Commision, Pakistan

Health Research Council of New Zealand

University of Auckland

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Biochemistry

Reference43 articles.

1. Metal-based anticancer chemotherapeutic agents

2. Classification of Metal-Based Drugs according to Their Mechanisms of Action

3. Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development

4. NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four new ruthenium(II) coordination compounds bearing coumarin derivatives as anticancer agents;Polyhedron;2024-11

2. Thioamides in medicinal chemistry and as small molecule therapeutic agents;European Journal of Medicinal Chemistry;2024-11

3. Expanding on the plecstatin anticancer agent class: exchange of the chlorido ligand for N-heterocyclic ligands;Australian Journal of Chemistry;2024-09-13

4. A multifaceted approach towards organometallic anticancer agent development;Journal of Organometallic Chemistry;2024-05

5. Exploring the phototoxicity of GSH-resistant 2-(5,6-dichloro-1H-benzo[d]imidazol-2-yl)quinoline-based Ir(iii)-PTA complexes in MDA-MB-231 cancer cells;Dalton Transactions;2024